Kidney Stone Management Market Rising in United States | Fortune Business Insights
The global kidney stone management market size is expected to rise prominently on account of the increasing cases of kidney stone among people worldwide. This is further attributed to the formation of crystal-like substances such as uric acid, oxalate, and calcium which cannot be diluted in the urine as a result of consuming food and drinks that are rich in phosphate and oxalate. A recent report by Fortune Business Insights, titled, “Kidney Stone Management Market Size, Share & COVID-19 Impact Analysis, By Type (Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithotomy (PCNL) By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Regional Forecast, 2020-2027,” states that the market was valued at USD 1.47 billion in 2019 and is anticipated to rise at a CAGR of 5.3% to reach USD 2.21 billion by the end of 2027.
Currently, the COVID-19 pandemic has brought about many
devastating effects on both human life and the world economy. Lockdown is
followed globally and this has impacted most businesses, both on national and
international levels. However, we hope to overcome this panic phase soon and
things would get back to normal with support from the government. We, at
Fortune Business Insights, are offering special reports on various markets that
have exhibited a significant impact owing to the coronavirus.
Get Sample PDF Brochure:https://www.fortunebusinessinsights.com/enquiry/sample/kidney-stone-management-devices-market-100450
|
North America |
United States, Canada and Mexico |
|
Europe |
Germany, UK, France, Italy, Russia and Turkey
etc. |
|
Asia-Pacific |
China, Japan, Korea, India, Australia, Indonesia,
Thailand, Philippines, Malaysia and Vietnam etc. |
|
South America |
Brazil, Argentina, Columbia etc. |
|
Middle East & Africa |
Saudi Arabia, UAE, Egypt, Nigeria and South
Africa |
LithoVue Empower™ Retrieval Deployment Device Launched by Boston Scientific will Pave a new Direction to Advanced Uterescopy
A leading
manufacturer of medical devices named Boston Scientific Corporation announced
the launch of its new kidney stone retrieval device called LithoVue
Empower™ Retrieval Deployment in September 2018. This new device is created for
operations in collaboration with the LithoVue™ Single-Use Digital Flexible
Ureteroscope, produced by the same company for assisting urologists in performing
ureteroscopy efficiently.
Dr Brian Matlaga, a professor of Urology at John Hopkins Medical Institutions, said, “The new LithoVue Empower Device will enhance the procedural bottlenecks at the time of kidney stone removal diagnostic processes. We guarantee quality care at a reduced cost of the procedure and excellent patient outcomes. We are aiming for the evolution of urologic and pelvic condition treatment.” Such innovations are expected to bode well for the urolithiasis management market in the forthcoming years.
The Report Answers the Following Questions:
- How
fierce is the kidney stone treatment devices market competition?
- Who
are the major players and what are their blueprints?
- Which
innovations will add impetus to the urolithiasis management market?
- Which
are the recent industry developments of the market?
About Us:
Fortune Business Insights™ delivers accurate data and innovative
corporate analysis, helping organizations of all sizes make appropriate
decisions. We tailor novel solutions for our clients, assisting them to address
various challenges distinct to their businesses. Our aim is to empower them
with holistic market intelligence, providing a granular overview of the market
they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Comments
Post a Comment